<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03340181</url>
  </required_header>
  <id_info>
    <org_study_id>B2017-100R</org_study_id>
    <nct_id>NCT03340181</nct_id>
  </id_info>
  <brief_title>Study on the Myocardial Protective Effect of Upper Limb Ischemic Preconditioning in Patients Undergoing Off-pump Coronary Artery Bypass Grafting</brief_title>
  <official_title>Study on the Myocardial Protective Effect of RIPC in Patients Undergoing OPCABG</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Zhongshan Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study was to verify the myocardial protective effect of RIPC in patients
      undergoing OPCABG.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      66 patients scheduled for OPCABG are randomly assigned to a RIPC group(n=33) or a control
      group(n=33). In the RIPC group, 4 cycles of 5-min ischemia(using a blood pressure cuff
      inflated to 40mmHg over the patient's basic blood pressure) and 5-min repercussion are done
      on an upper limb before skin incision. Patients in the control group wear the same cuff on an
      upper limb but no pressure is applied. Anesthetic and surgical techniques are standardized
      during the trial. Serum inflammatory cytokines and cardiac injury markers will be measured
      before and after surgery. Internal mammary artery and saphenous vein tissues will be
      collected during the surgery to assess hypoxia-inducible factor (Hif)-1a and other signalling
      proteins.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ICU staying time</measure>
    <time_frame>average of 1 year</time_frame>
    <description>the time patients spend in ICU after surgery</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>OPCABG</condition>
  <arm_group>
    <arm_group_label>RIPC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4 cycles of 5-min ischemia(using a blood pressure cuff inflated to 40mmHg over the patient's basic blood pressure) and 5-min repercussion are done on an upper limb.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>patient in control group using a blood pressure cuff on an upper limb without inflating</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>RIPC</intervention_name>
    <description>4 cycles of 5-min ischemia(using a blood pressure cuff inflated to 40mmHg over the patient's basic blood pressure) and 5-min repercussion are done on an upper limb before skin incision.</description>
    <arm_group_label>RIPC</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  serious changes in several coronary arteries that need to receive OPCABG

          -  NHYA II-III

          -  ASA II-III

        Exclusion Criteria:

          -  LVEF&lt; 35%

          -  acute myocardial infarction

          -  multiple organ dysfunction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hui-lin Wang, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fudan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ke-fang Guo, Phd</last_name>
    <phone>021-64041990</phone>
    <email>guo.kefang@zs-hospital.sh.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Huilin Wang</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200233</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wang Huilin, PH.D</last_name>
      <phone>13918270670</phone>
      <email>mumuwang1019@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2017</study_first_submitted>
  <study_first_submitted_qc>November 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2017</study_first_posted>
  <last_update_submitted>November 8, 2017</last_update_submitted>
  <last_update_submitted_qc>November 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>RIPC, myocardial protective effect</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

